Navco Pharmaceuticals (TSXV:NAV) Accounts Payable & Accrued Expense : C$0.09 Mil (As of Mar. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Navco Pharmaceuticals Accounts Payable & Accrued Expense?

Navco Pharmaceuticals's quarterly accounts payable & accrued expense declined from Sep. 2022 (C$0.11 Mil) to Dec. 2022 (C$0.10 Mil) and declined from Dec. 2022 (C$0.10 Mil) to Mar. 2023 (C$0.09 Mil).

Navco Pharmaceuticals's annual accounts payable & accrued expense declined from Jun. 2019 (C$0.02 Mil) to Jun. 2020 (C$0.02 Mil) and declined from Jun. 2020 (C$0.02 Mil) to Jun. 2021 (C$0.02 Mil).

Navco Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Navco Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navco Pharmaceuticals Accounts Payable & Accrued Expense Chart

Navco Pharmaceuticals Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Accounts Payable & Accrued Expense

0.02

Navco Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial														0.06	0.11	0.11	0.10	0.09

Navco Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Navco Pharmaceuticals (TSXV:NAV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navco Pharmaceuticals Inc (TSXV:NAV) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6E 4N7

Website

Navco Pharmaceuticals Inc uses of nanotechnology to develop and commercialize novel products to protect against viruses, bacteria, and infectious diseases. The company's pipeline of applications is tailored to defend against pathogens utilizing new methods of action to capitalize on unmet product needs using natural & known compounds, nanoparticles, and no chemicals with a high degree of efficacy. Its target markets include human health & personal skin care, household & institutional products, and veterinary health.